Journal
Neurology. Genetics
ISSN: 2376-7839
Titre abrégé: Neurol Genet
Pays: United States
ID NLM: 101671068
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
04
05
2020
accepted:
19
08
2020
entrez:
2
11
2020
pubmed:
3
11
2020
medline:
3
11
2020
Statut:
epublish
Résumé
To further clarify the molecular pathogenesis of RNA polymerase III (Pol III)-related leukodystrophy caused by biallelic Exome analysis and molecular functional studies using cell expression and long-read sequencing analyses were performed on 1 family with hypomyelinating leukodystrophy showing no clinical and MRI findings characteristic of Pol III-related leukodystrophy other than hypomyelination. Biallelic novel The lack of characteristic clinical findings in this family confirmed the broad clinical spectrum of Pol III-related leukodystrophy. Molecular studies suggested that dysregulation of splicing is the potential downstream pathomechanism for
Identifiants
pubmed: 33134519
doi: 10.1212/NXG.0000000000000524
pii: NG2020014241
pmc: PMC7577547
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e524Informations de copyright
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Références
Neurology. 2006 Dec 12;67(11):2066-9
pubmed: 17159124
Nat Commun. 2015 Jul 07;6:7623
pubmed: 26151409
J Med Genet. 2013 Mar;50(3):194-7
pubmed: 23355746
Brain Dev. 2009 Sep;31(8):582-7
pubmed: 18851904
Congenit Anom (Kyoto). 2020 May;60(3):91-93
pubmed: 31322785
Am J Hum Genet. 2011 Nov 11;89(5):644-51
pubmed: 22036171
Neurol Genet. 2019 Oct 30;5(6):e369
pubmed: 32042905
RNA. 2018 Apr;24(4):437-460
pubmed: 29367453
Am J Hum Genet. 2011 Sep 9;89(3):415-23
pubmed: 21855841
Mol Genet Genomic Med. 2019 Sep;7(9):e914
pubmed: 31368241
Neurology. 2014 Nov 18;83(21):1898-905
pubmed: 25339210
J Child Neurol. 2014 Feb;29(2):214-20
pubmed: 24105487